EUVIMEDEUVIMED entdecken
Open Access

Symptom factors and their clinical correlates among adults with cystic fibrosis

Natalia Smirnova, Scott Gillespie, Jane Lowers, Andrew Jergel, Elisabeth P Dellon, Alexandre Cammarata-Mouchtouris, Anne Fitzpatrick, Dio Kavalieratos

Journal of Cystic Fibrosis · 2025

DOI: 10.1016/j.jcf.2025.07.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Natalia Smirnova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quality of Life, Symptom Assessment, Palliative Care. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite cystic fibrosis transmembrane conductance (CFTR) modulator therapy that may dramatically alter the course of disease, many people living with cystic fibrosis (PwCF) experience co-occurring symptoms that may be interrelated and may synergistically degrade quality of life. We sought to identify symptom factors, or groups of correlated symptoms, connected by underlying latent variable(s). We then examined demographic and clinical characteristics associated with these groups among PwCF. METHODS: Using baseline data from a trial of specialist palliative care in PwCF, we assessed symptoms with the Memorial Symptom Assessment Scale-CF. We used exploratory factor analysis followed by confirmatory factor analysis to identify and validate symptom factors. For each factor (using only the symptoms identified in the factor), we then created a binary variable (Symptom Factor Severity) that identified patients as Low versus High Severity, by mean splitting the sum of each patient's severity symptom scores for that factor. Multivariable logistic regression was used to examine associations between demographic and clinical characteristics with each split Symptom Factor Severity score. RESULTS: Among 262 participants, median age was 33 years, and 78 % were prescribed a CFTR modulator. We identified three symptom factors: respiratory-energy, mood-gastrointestinal irritability, and pain-gastrointestinal dysmotility. High symptom severity in each factor was associated with specific demographic and clinical characteristics. CONCLUSIONS: CF symptom management strategies have historically focused on single-symptom approaches. Findings from this study may prompt clinicians to consider co-occurring symptoms, and ensure their assessment and management is tailored to the unique experiences of PwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuality of LifeSymptom AssessmentPalliative CareHumansAdultMaleFemaleSeverity of Illness IndexCystic Fibrosis Transmembrane Conductance Regulator

Stichwörter der Autor:innen

Palliative careQuality of lifeSymptom managementSymptom science

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, USA.
  • Pediatrics Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, GA, USA.
  • Division of Palliative Medicine, Department of Family and Preventive Medicine, Emory University, Atlanta, GA, USA.
  • Department of Pediatrics, UNC Chapel Hill, Chapel Hill, NC, USA.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, GA, USA; Pediatrics Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, GA, USA;…
  • Division of Pulmonology, Asthma, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University, Atlanta, GA, USA.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • Cystic Fibrosis Foundation

Zitieren

APA

Smirnova, N., Gillespie, S., Lowers, J., Jergel, A., Dellon, E. P., Cammarata-Mouchtouris, A., Fitzpatrick, A., & Kavalieratos, D. (2025). Symptom factors and their clinical correlates among adults with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.07.001

Vancouver

Smirnova N, Gillespie S, Lowers J, Jergel A, Dellon EP, Cammarata-Mouchtouris A, et al. Symptom factors and their clinical correlates among adults with cystic fibrosis. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.07.001

BibTeX
@article{Smirnova2025,
  author = {Smirnova, Natalia and Gillespie, Scott and Lowers, Jane and Jergel, Andrew and Dellon, Elisabeth P and Cammarata-Mouchtouris, Alexandre and Fitzpatrick, Anne and Kavalieratos, Dio},
  title = {Symptom factors and their clinical correlates among adults with cystic fibrosis},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  doi = {10.1016/j.jcf.2025.07.001}
}
Kostenlos starten →